Recombinant equine lubricin is safe and well tolerated following multiple intra-articular injections in healthy fetlock joints
American Journal of Veterinary Research · 12.11.2026 · 1-11
DOI: 10.2460/ajvr.26.08.0366 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, erschienen am 12.11.2026. Verfasst von Machiel P Ysebaert und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To assess the safety of recombinant equine lubricin (rEqLub) injections in healthy equine fetlocks using clinical, biochemical, and histological outcomes.
Methods
6 adult horses were enrolled (3geldings, 3mares) in a block randomized, controlled experimental study. All 24 fetlocks were assigned to receive an injection of either 2 mL rEqLub (1mg/mL) or PBS at 1 of 3 time points. Recombinant equine lubricin was injected into a randomized forelimb at 28 days and 1 day prior to study completion, and rEqLub and PBS were injected into contralateral hindlimbs at 7 days prior to study completion. Clinical and orthopedic examinations were performed at baseline and prior to and 1 day following each injection; synovial fluid was collected for biochemistry, flow cytometry, and proteomics; synovial membrane and osteochondral sections were collected from day-28 rEqLub-treated joints and scored using Osteoarthritis Research Society International criteria.
Results
3 sequential IA injections of rEqLub in 3 different healthy fetlocks were well tolerated and did not result in adverse clinical or histologic outcomes. There were no differences in clinical or synovial fluid biochemical parameters between rEqLub- and PBS-injected joints. Synovial fluid WBC concentrations and total protein were increased 1 day after injection in rEqLub-treated joints.
Conclusions
IA rEqLub did not cause any detectable clinical, biochemical, or histological adverse effects, supporting the favorable tolerability and safety profile of rEqLub. The small sample size and multijoint design are limitations. Clinical Relevance rEqLub injections were well tolerated, establishing a basis for future equine efficacy trials to evaluate the ability of recombinant lubricin to mitigate osteoarthritis in a clinically relevant equine model.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY.
- Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO.
- Smith School of Chemical and Biomolecular Engineering, College of Engineering, Cornell University, Ithaca, NY.
- Department of Biomedical Engineering, College of Engineering, University of California-Davis, Davis, CA.
- Department of Surgical and Radiological Sciences, Weill School of Veterinary Medicine, University of California-Davis, Davis, CA.
ORCID-Profile: Machiel P Ysebaert, Matthew Thomas, Erica J Secor, Heidi L Reesink
Zitieren
APA
Ysebaert, M. P., Thomas, M., Secor, E. J., Colville, M. J., Gier, C. J., Cervero, I., McKane, A., Paszek, M. J., & Reesink, H. L. (2026). Recombinant equine lubricin is safe and well tolerated following multiple intra-articular injections in healthy fetlock joints. American Journal of Veterinary Research, 1-11. https://doi.org/10.2460/ajvr.26.08.0366
Vancouver
Ysebaert MP, Thomas M, Secor EJ, Colville MJ, Gier CJ, Cervero I, et al. Recombinant equine lubricin is safe and well tolerated following multiple intra-articular injections in healthy fetlock joints. American Journal of Veterinary Research. 2026:1-11. doi:10.2460/ajvr.26.08.0366
BibTeX
@article{Ysebaert2026,
author = {Ysebaert, Machiel P and Thomas, Matthew and Secor, Erica J and Colville, Marshall J and Gier, Collin J and Cervero, Isabella and McKane, Anna and Paszek, Matthew J and Reesink, Heidi L},
title = {Recombinant equine lubricin is safe and well tolerated following multiple intra-articular injections in healthy fetlock joints},
journal = {American Journal of Veterinary Research},
year = {2026},
pages = {1--11},
doi = {10.2460/ajvr.26.08.0366}
}
EUVIMED